BUY DLF Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))4 Sept 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·21 Sept · today
DLF to open ₹500 crore Goa mall by March 2027, eyes over ₹150 crore annual rental income
NewsEt-Markets·19 Sept · yesterday
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·17 Sept · 3d ago
M3M emerges as highest bidder for prime Noida land parcels at ₹1,850 crore
NewsEt-Markets·9 Sept · 2w ago
Nifty Realty Index Rises 3% Amid Strong Luxury Housing Demand
NewsGoogle News·3 Sept · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on DLF
- SELL — Arun Kumar Mantri21 Oct 2026 · ~3 months · target ₹610 · Active
- BUY — J.P. Morgan19 Oct 2026 · ~1 year · target ₹800 · Active
- BUY — Jefferies India19 Oct 2026 · ~1 year · target ₹830 · Active
- BUY — Chandan Taparia, Motilal Oswal19 Oct 2026 · ~2 weeks · target ₹720 · Active
- BUY — Milan Vaishnav19 Oct 2026 · ~2 weeks · target ₹705 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

